WO2001029558A1 - A test strip provided device with a lid-provided pretreatment portion - Google Patents
A test strip provided device with a lid-provided pretreatment portion Download PDFInfo
- Publication number
- WO2001029558A1 WO2001029558A1 PCT/FI2000/000914 FI0000914W WO0129558A1 WO 2001029558 A1 WO2001029558 A1 WO 2001029558A1 FI 0000914 W FI0000914 W FI 0000914W WO 0129558 A1 WO0129558 A1 WO 0129558A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- layers
- pretreatment
- lid
- test device
- sample
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 174
- 239000000523 sample Substances 0.000 claims abstract description 63
- 239000012488 sample solution Substances 0.000 claims abstract description 30
- 239000003085 diluting agent Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 22
- 239000003153 chemical reaction reagent Substances 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 15
- 239000011148 porous material Substances 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 claims description 8
- 102000008857 Ferritin Human genes 0.000 claims description 7
- 108050000784 Ferritin Proteins 0.000 claims description 7
- 238000008416 Ferritin Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 230000002452 interceptive effect Effects 0.000 claims description 7
- 238000003556 assay Methods 0.000 claims description 4
- 230000007613 environmental effect Effects 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 230000004523 agglutinating effect Effects 0.000 claims description 2
- 230000003139 buffering effect Effects 0.000 claims description 2
- 230000001112 coagulating effect Effects 0.000 claims description 2
- 230000002101 lytic effect Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 239000000356 contaminant Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 14
- 239000012528 membrane Substances 0.000 description 13
- 239000004033 plastic Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- 229920001778 nylon Polymers 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000001179 synovial fluid Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 210000004381 amniotic fluid Anatomy 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000003312 immunocapture Methods 0.000 description 2
- 238000012125 lateral flow test Methods 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 238000011045 prefiltration Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001279364 Stachybotrys chartarum Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- -1 agglutination Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
Definitions
- the present invention is related to a test device with a lid- provided pretreatment portion mounted on the same backing support as a test strip and having means for controlled regulation of sample and diluent flow.
- a method for directly carrying out assays from samples generally requiring more or less time consuming pretreatment procedures with said device is also disclosed.
- Some biological samples especially such samples which are taken for making diagnoses from whole blood, serum, urine, feces, saliva, sputum, synovial fluid, etc. require pretreatment procedures including removal of particles, agglutination, chemical treatments, release of specific components, immuno- capture, etc.
- Some problems are related to said known systems . Said problems are for example backflow of diluting buffers and overflow, i.e. redundant fluid may pass the edges of the filtering means, leaving the reagents in the reagent layer and causing disturbances in the detection zone.
- Another problem connected with said known methods and devices is that only one filtering pad or layer is often not sufficient to retain all blood cells and all interfering factors are not retained either.
- the objective of the present invention is to provide a test device with a test-strip and improved lid-provided pretreatment portion having means for regulating the sample and diluent flow.
- Said device is useful in emergency situations, especially for use in ambulances wherein coagulation and centrifugation is not possible to carry out or in which said steps are too time consuming.
- On the test device of the present invention even complicated immunological analysis can be performed rapidly with great accuracy without pretreatment of the sample.
- the test device can be modified to meet the requirements in a multitude of different test methods .
- the invention relates to a test device for obtaining a controlled regulation of sample and diluent flow.
- Said test device has a pretrea- ting portion for treating the sample and removing interfering substances and particles before performing the assays on a test-strip placed on the backing support (1) .
- the pretreatment portion is provided with a lid (2) having an aperture (3) .
- Said lid covers and protects the pretreatment system having one or more pretreatment layers (4) horizontally stapled upon each other and assembled in capillary flow contact with the test strip (5) , which is placed on the lid-provided backing support (1) .
- the backing support (1) and the lid (2) are provided with means for keeping the layers (4) in the pretreatment system in their correct positions and to connect them with the test strip (5) .
- Said means for securing and fixing the position of the layers are responsible for a controlled regulation of the flow of the sample solution.
- Said means also form an excess liquid collecting compartment (6) , which enables rapid addition of buffer or other liquids in order to allow more efficient dilution of sample and reagents impregnated into the layers.
- the compartment (6) minimizes the negative effects of overflow and backflow and enables an even and controlled passage through each layer in a predetermined order and subsequently into the test strip (5) where the result is recordable as one or more visable or readable zones.
- the invention relates to a method for carrying out a rapid bed-side or field test without pretreating the sample.
- the sample is added into the aperture (3) in the lid (2) on the backing support (1) of the test device and a diluent or aqueous driving solution is added.
- the diluent may contain agents, which are essential for properly carrying out the test .
- the diluent which may be a buffer or pure water is capable of driving the sample solution and diluents through the layers in the pretreatment system in a controlled manner. Particles are captured and interfering substances are removed or allowed to react by using physical and/or chemical means in the layers of the pretreatment system. Superfluous or excess fluid is collected in the compartment formed by the bar (9.1) in the lid and the flanking support (8.1) and the bar (9.4) in the lid-portion of the backing support.
- Fig. 1 is a side view of a lid-provided backing support (1) and the lid (2) with a hinge (A) .
- the lid is snapped in place with the means for attaching the lid (C) to protect the layers in the pretreatment system.
- Fig. 2 is a schematic view from above of the test device with a closed lid (2) snapped on the backing support (1) and the test strip (5) fixed in its correct position.
- the lid (2) is provided with a shaped or non-shaped aperture (3) into which the sample solution and possible diluents or driving solutions can be added.
- Fig. 3 is a sectional side-view of the lid-provided backing support (1) with the lid (2) open.
- the aperture (3) for adding sample solution is seen as an intersection.
- Two pretreatment layers (4.1) and (4.2) as well as the test strip (5) are schematically shown.
- Fig. 4 shows a view from above of the lid-provided backing support (1) with the lid (2) open and the aperture (3) shown as a round dot or spheric area and with the pretreatment layers (4.1) and (4.2) as well as the test strip (5) placed in their correct positions.
- Fig. 5 is a sectional side view of the lid-provided backing support (1) with the lid (2) snapped on the backing support (1) and covering and protecting the pretreatment layers (4.1) and (4.2) .
- the pretreatment layers are in capillary flow contact with the test strip through the conjugate pad (B) . All layers are placed in their correct positions.
- Fig. 6 is a sectional view seen from above with a transparent closed lid (2) and the aperture (3) snapped on the backing support (1) . Due to the transparency the lid-covered pretreatment layers (4) , which normally are not seen, can be seen in their correct positions and in capillary flow contact with the test strip (5) . The transparency is not a prerequisite in the present invention. Transparency was used during developmental work for experimental purpose to enable studies of what is going on in the different layers.
- Fig. 7 is a sectional side view of the lid-provided backing support (1) with the lid (2) open and without pretreatment layers and without the test strip.
- the means for securing and fixing the layers in their correct positions are shown. These means include taps (7) , flanking supports (8) and bars (9) .
- Fig. 8 is a schematic picture viewed from above of the lid- provided backing support (1) with the lid (2) open without pretreatment layers and without the test strip.
- Fig. 9 is a sectional side view of the lid-provided backing support (1) with the lid (2) snapped in place without pretreatment layers and test strip. In this Figure the space provided for the layers is clearly indicated.
- Fig. 10 is a sectional view seen from above with a transparent closed lid (2) snapped on the backing support (1) and without the pretreatment layers and without the test strip.
- the aperture (3) is shown in this Figure as well as the taps (7) and the side wall protrusions forming the flanking supports (8) .
- the bar (9.4) which forms the reservoir of the compartment is clearly indicated.
- the term "means for securing and fixing the position of the layers” are responsible for a controlled regulation of the flow of the sample solution and appropriate diluents. They also form a compartment for collecting excess fluid or liquid. This compartment allows efficient dilution of reagents. It minimizes the effects of overflow. Simultaneously, negative backwash effects are avoided. The compartment enables an even and controlled passage through each layer in a predetermined order and subsequently into the test strip.
- the "means for securing and fixing the position of the layers” are provided by taps, flanking supports and bars, which are longer or shorter protrusions present in the plastic lid and the lid-portion of the backing support of the device . The means have somewhat different functions.
- backwash effect and/or “backflow effect” means the phenomenon when the sample solution and the liquid, acting as a diluent, drives the sample solution in the wrong direction, i.e. in a direction opposite to the intended one. In the worst case, the sample flows over the reaction area and the reagents are washed back. In the present invention, uncontrolled backwash is not possible.
- the negative backwash effect is abolished, because the excess fluid is collected behind the pretreatment layers in a compartment, which is later emptied, when the excess fluid from the compartment migrates through the filter layers into the conjugate pad and the reagent area of the test strip by capillary forces of the absorbing pad in the opposite end of the test strip.
- tap means smaller protrusions, such as pegs or tags on the bottom of the plastic backing of the device . Said taps support the filtering means and prevent them from lying directly on the backing support. Alternatively, a grid can be used. Thus, the sample solution and the diluent cannot flow along the backing support. In other words, the sample solution is prevented from passing into the test strip without first passing the filters.
- flanking support means protrusion in the backing support which keep the pretreatment layers in fixed positions.
- One flanking support in the rear of lid-portion of the backing support assists in forming the excess fluid compartment.
- the flanking supports in the side walls also prevent excess fluid from migrating into the test strip without first passing the pretreatment layers .
- bars mean ridges and ribs which can be “toothed” in order to provide a better grip. Such a “toothed bar” is present in the lid and keeps the test strip in a firm grip.
- the bars may also form the wall of the compartment for excess fluid and prevents the excess fluid from flowing under the filter layers.
- the bars together with the flanking supports also fix the pretreatment layers in their correct positions.
- test strip and/or "test stick” means a laminated strip or stick comprising for example a nitrocellulose or nylon membrane mounted on a backing.
- the test strips or sticks are provided with reagents preferably immunoreagents such as mono- or polyclonal antibodies and further provided with recordable or visible markers or labels.
- the test sticks can alternative be enzymatic, chemical or biochemical.
- aperture means a shaped or non- shaped hole for adding the sample and/or diluent.
- test strip is an immunochromatographic test producible as follows:
- a nitrocellulose or nylon membrane is mounted on a plastic backing or between plastic strips and is provided with a conjugate pad in close contact with one end of a nitrocellulose or nylon membrane and with an absorbent pad attached to the other end of the membrane.
- a narrow zone on the nitrocellulose or nylon membrane is coated with a monoclonal antibody against a specific component. Coloured or fluorescent latex particles, as well as colloidal particles, gold sols, magnetic particles, etc. may be coated with another antibody preferably a monoclonal antibody against the same component .
- the coated particles are dried on a zone preferably close to the pretreatment portion of the strip or in a layer placed in the pretreatment portion. The diameter of the particles is so small that they can flow freely through the pores and strip materials.
- the layers and the test strips are placed on a plastic backing so that they are in a capillary flow contact of the sample liquid to test strip through the appropriate filter layers .
- test strip is, however, not restricted to the test strip embodiment described above.
- test devices and determinations which require pretreatment of the sample can be used in the present test device including immuno- assays as well as enzymatic, chemical or biochemical test strips .
- the test device of the present invention is provided with a lid-provided pretreatment area, comprising one or more layers, preferably of a hydrophilic, bibulous material, stapled upon each other. They provide means for physical or chemical treatment of the sample.
- Said pretreatment area is provided with a lid or cover of plastic material with good wetting properties and means for keeping the layers fixed in a predetermined position with each others and with the test strip.
- the cover or lid is optionally loose or attached to the backing support by fastening means such as hinges or pivots.
- the fastening means can be placed on any side of the backing support, but the most preferable place is in the near, i.e. at the outer or upper end of the backing support. If the hinges are placed on either side, the flow of the sample solution may not be even, i.e. it can be different on different sides of the layers. When the pretreatment layers and the test strip are assembled the lid is snapped over the pretreatment portion.
- the layers in the pretreatment system comprise one or more different layers, which allow physical as well as chemical pretreatment of the sample.
- Said physical treatment includes separation or removal of certain components or particles or means for regulating the mobility of the components in the sample solution.
- filters or membranes with different pore sizes or with shaped pores are used.
- filters having different so called V-pores i.e. having pores with different diameters on each side of the filter or filters having different pore sizes on each side are used for separating particles of different sizes in the sample solution.
- the layers in the pretreatment portion can in addition to providing physical treatment comprise means for chemical treatment of the sample .
- Said means for chemical treatment are filters or membranes containing certain compounds or compositions acting as agglutinating, coagulating, lytic, buffering and ionic strength regulating agents as well as immunocap- turing agents .
- the layers can also be used as carriers for so called labels or markers, including coloured, phosphorescent or fluorescent latex particles, colloids, gold sols, lipo- somes, etc. It is also possible to add chemical substance, which are capable of releasing specific components from the substances which are to be determined.
- the test device comprises a supporting back preferably prepared by good quality, wettable, plastic material, such as polypropens . Because of the hinges or pivots, it is essential that the material is substantially non-brittle. Furthermore, the material should not contain any disturbing chemicals. It is for example not recommendable to use mold releasing agents or plasticizers for the preparation of the lid and backing support. Surface treatments are not recommendable.
- the backing support is provided with a lid preferably made of the same material as the backing support.
- the lid covers the pretreatment portion and simultaneously fixes the test strip in capillary flow contact with the pretreatment layers.
- the sample solution has to pass all the required layers before entering the test strip by capillary flow.
- the backing support and the lid of the test device act as a protector for the test strip during storage and transport. Otherwise the test strip itself is not covered.
- the inside of the lid, as well as the pretreatment portion of the test device, is provided with means, including taps (7) , flanking supports (8) and bars (9), which fix the layers of the pretreatment portion firmly with each others and the test strip.
- the contact between the test strip and the pretreated sample solution is made feasible only through the aperture in the lid.
- the sample solution flows by capillary forces through the pretreatment layers into the test strip.
- the lid is constructed to enable a firm capillary flow contact between the sample solution and the test strip through the pretreatment layers, e.g. the filters in the desired and predetermined order.
- the pretreated sample solution migrates only through the pretreatment layers into the test strip. Redundant or excess fluid is temporally collected in a compartment (6) formed by the bar (9.4) in the lid portion of the backing support .
- test strip can be placed into the test device during the manufacture and sold as a ready to use disposable kit.
- test strip, test device and layers for the pretreatment portion can be sold separately and assembled in desired manner before use.
- the sample can be whole blood, serum, urine, feces, saliva, sputum, synovial fluid, amniotic fluid, but also environmental samples of different forms. Generally, it is essential that particular and/or solid material can be removed from the sample. This can be achieved with filtering means such as a pad with suitable pore sizes. Sometimes, the sample has to be chemically treated in order to separate interfering or disturbing components. Sometimes, some specific or active components in the substances to be determined from the sample have to be released before they can be determined. Such components are for example epitopes or active sites in certain proteins or haptens . The release can be carried out e.g. by extraction using different reagents, such as detergents, reducing agents, acids, etc. The agents remove for example sulphur- bridges, lipid, etc.
- the test device is preferably used with samples requiring different kinds of pretreatments .
- the lid-provided portion of the test device may contain one layer of material, or several layers of the same material or of different types of materials . These materials can e.g. have different pore sizes, and may be used as pre- filters . They can be impregnated with different kinds of reagents and they may act as reagent layers or as immunocap- ture layers . These layers may be used separately or in any combination with each other.
- sample specimen When the sample specimen is whole blood, separation of blood cells is usually required. This can be achieved by preferable using two layers of material in close contact with the lateral flow test strip.
- the upper layer is preferably acting as a sample pad.
- the sample pad together with the underlaying filter separates blood cells from whole blood allowing plasma or sera to migrate forward to the test strip.
- the lid-provided portion may contain layers impregnated with reagents for eliminating these interfering substances .
- the serum specimen can be applied to a layer acting as a sample pad and eluted with a buffer containing such reagents.
- a driving solution either water or preferably a buffer is added.
- the driving solution dissolves and mixes the sample and reagents and drives them through the pretreatment layer (s) into the test strip and the zone where the result can be read.
- the buffer is known to cause problems such as backflow.
- the present invention solves said backflow problem by collecting any liquid flowing backwards into the compartment behind the filter (s), but thereafter the compartment is efficiently emptied by capillary forces and all sample and reagents are transferred to the test strip.
- the lid-provided portion may contain one or more layers of filters with the same or with different pore sizes.
- a prefilter with a coarse pore structure may lay on the top of one pretreatment layer with a fine pore structure. Large and small particles can subsequently be filtered away before the sample liquid reaches the test strip.
- the sample specimen is a urine sample, having for example a very low pH value, caused e.g. by a preservative, or a very low ionic strength, it may preferably be pretreated in one or several buffered layers before the sample liquid reaches the test strip.
- sample specimen is saliva, sputum, synovial fluid or amniotic fluid it may be preferable to use mucous dissolving agents impregnated into the layers of the pretreatment portion.
- the sample is added to the test device through the aperture in the lid of the pretreatment portion.
- the volume of the sample can be such, that no additional reagent solution is needed.
- a diluent solution preferably an aqueous buffer is necessary in order to get a flow of liquid from the pretreatment portion to the end of the test strip in the device.
- sample liquid to the opening in the lid is preferable added drop-wise.
- the first drop of liquid spreads through the top layer of the filters, i.e. the hydrophilic, bibulous sample pad.
- the further drops flow through the sample pad into the underlaying filter layer and spread horizontally into the back compartment (6) in the lid-portion of the backing support.
- the filter materials are all in close contact with each other, and with the bibulous filter part or conjugate pad (B) of the test strip (5) .
- the pretreatment layers or filters are laying on taps (7) in the plastic device, and they are in turn held in place by flanking supports (8) in such a way, that the liquid is forced to flow through the filter and/or reagent layers in a predetermined order and not along the inner surface of the plastic device.
- the sample liquid with or without the diluent or driving solution is spread along the underlaying filter(s) (4), and wets the end of the test strip (5), i.e. the conjugate pad (B) .
- the excess fluid collecting compartment (6) of the lid- portion in the rear end of the backing support is emptied as the liquid flows forward along the conjugate pad (B) and further into the membrane part of the test strip driven by capillary forces which are provided by the absorbant pad in the opposite end of the test strip (5) .
- Microspheres e.g. latex particles covered with an antibody, dried upon the conjugate pad redissolve, and migrate forward with the liquid front into the reaction area on the membrane of the test strip.
- the absorbent pad in contact with the membrane of the test strip absorbs excess liquid and ensures that the compartment (6) will be emptied.
- the sample is preferably pipetted into the hole or aperture on the cover or lid of the test device and optionally a suitable buffer solution is added for driving the sample through the layers .
- the solution is forced through a first filter layer which removes greater components or particles into the following layer. Behind the layers is a compartment (6) into which excess liquid can be collected so that it is not forced beside and over the pretreatment layers (4) into contact with the nitrocellulose or nylon membrane of the test strip (5) . Furthermore, the sides of the backing support (1) and the lid (2) is provided means (7, 8 and 9) for attaching the different layers in fixed positions.
- the means provided are for example in form of a grid lattice or more preferably in the form of taps (7) .
- the grid or taps (7) are supporting the pretreatment layers so that they do not touch the backing support (1) .
- the flanking supports (8) prevent the sample solution from passing along the sides of the filters.
- the lid (2) and support (1) is provided with bars (9) .
- the lid (2) is provided with a toothed bar (9.3) which keeps the test strip in place.
- the lid-portion of the backing support is also provided with a bar (9.4), which assisted with the flanking support (8.1) forms the compartment (6) for redundant or excess fluid.
- the test is allowed to develop without any pos- sibly disturbing movements until the result is visible or readable.
- the result is recorded directly. It is preferable that the amount of sample and diluent is such that solution is absorbed and not left in the excess liquid collecting compartment ( 6 ) .
- test device of the present invention and the use thereof for performing analyses with a test strip or test stick is described in more detail by referring to the attached Figures 1-10, wherein the reference numbers and/or letters used refer to the corresponding features independent of the design of the test device .
- Fig. 1 is a side view of a lid-provided backing support (1) with an edge and the lid (2) snapped in place with the means for closing (C) the lid by snapping to protect the layers in the pretreatment system.
- the backing support and the lid portion are connected with suitable fastening means, such as hinges (A) or pivots placed in the rear of the test device in the most preferred embodiment of the present invention.
- Fig. 2 is a schematic picture of the closed lid (2) snapped on the backing support (1) and with the pretreatment layers (not shown) hidden under the lid and the test strip (5) fixed in their correct position.
- the lid (2) is provided with a preferably shaped aperture (3) into which the sample solution and a possible diluent or driving solution can be added and also with means for closing (C) the lid.
- Fig. 3 is a sectional side-view of the lid-provided backing support (1) with the lid (2) open.
- the aperture (3) for adding the sample solution is shown as an intersection and two pretreatment layers (4.1) and (4.2), which include for example a first filter pad (4.1) and a second filter pad (4.2) and the bibulous area of the test strip (5) are schematically shown as well as the fastening means or hinge (A) in the rear of the test device.
- the conjugated area in which the filter (4.2) is in capillary flow contact with test strip (5) is indicated with the letter (B) and the means for closing (C) the lid by snapping over the pretreatment portion is indicated with (C) .
- taps (7) and bars (9.1), (9.2) and (9.3) which support the layers in the pretreatment portion and a flanking support (8.1) and a bar (9.4) which form a compartment (6) or reservoir basin for excess or redundant fluid.
- Fig. 4 shows a view from above of the lid-provided backing support (1) with the lid (2) open, the aperture (3) for adding sample and with the pretreatment layers (4.1) and (4.2) and the test strip (5) placed in the correct positions.
- the flanking support (8.1) and bar (9.1) forming the reservoir compartment (6) as well as the side wall protrusions or flanking supports (8.2) preventing excess fluid from passing around the filters and the bars (9.1), (9.2) and (9.3) which fix the layers are also indicated.
- the fastening means or hinge (A) and filter layer-test strip-connecting area, the conjugate pad (B) as well as the snapping or closing means (C) are schematically shown.
- An enlarged view of one preferred embodiment of the toothed bar (9.3), which prevents the test strip from moving, is shown in detail seen from the rear end of the lid and the backing support .
- Fig. 5 is a sectional side view of the lid-provided backing support (1) with the lid (2) with the aperture (3) snapped on the backing support and covering and protecting the pretreatment layers (4.1) and (4.2) and connected with the test strip (5), all placed in their correct positions.
- the fastening means or hinge (A) and the connection area, conjugate pad (B) between the filter (4.2) and test strip (5) as well as the snapping region (C) are also schematically shown.
- the taps (7) which support the layers as well as the flanking support (8.1) and the bar (9.4) which form the compartment (6) .
- the compartment area collect excess fluid and prevents it from passing around the filters.
- Fig. 6 depicts a view seen from above with a closed transparent lid (2) and the aperture (3) on the backing support (1) . Also seen are the layers of which (4.1) is a prefilte- ring pad and the filter (4.2) is connected with the test strip (5) . Side wall protrusions and/or flanking supports (8.2) are also shown on each side of the filter layers as well as a flanking support in the rear end (8.1) .
- the area marked (B) indicates the filter-test strip connecting area, the conjugate pad and (C) the snapping area.
- Fig. 7 is a cross-sectional side view seen from one side in longitudinal direction of the lid-provided backing support with the lid portion (2) open and without pretreatment layers and test strip.
- the lid portion (2) is attached to the backing support (1) with hinges (A) , which preferably are placed in the rear of the lid portion of the backing support (1) and not on either side of the lid portion in order to avoid uneven mobility or flow of the sample fluid.
- the backing support comprises two portions.
- the lid portion being the sample pretreatment portion is covered by the lid (2) and the assay portion carries the test strip (not shown) .
- the lid (2) is provided with a shaped aperture (3) and the backing support with a side wall in the backing support (1.1) the inside of which is shown in this Figure.
- the lid (2) is snapped to the backing support (1) and the bars (9.1), (9.2) and (9.3) which can be of different heights and breadths can be used to fix the filtering layers. They act as fastening and supporting means for the layers and the test strip (not shown) . They can also be placed so that they form a separate compartment (6) for collecting excess or redundant sample fluid and enable an even flow into the test strip or test membrane.
- the backing support (1) of the lid portion is also provided with flanking supports (8.2) and/or taps (7) of different heights which are adjusted so that they support differently shaped and sized filter layers.
- the filter layers are of different thickness and different sizes (dimensions) .
- the flanking support (8.1) and the bar (9.4) forms the compartment (6) which acts as a reservoir basin for redundant or excess sample fluid.
- Fig. 8 is a schematic picture viewed from above of the lid- provided backing support (1) with the lid (2) open without pretreatment layers and test strip.
- the lid (2) and the supporting back (1) are connected by the fastening means or hinge (A) .
- the aperture (3) is a shaped hole into which the sample is added or pipetted.
- the lid (2) is further provided with bars (9.1), (9.2) and (9.3) of different height which keep the different filter layers in desired places.
- the bar (9.1) in the lid and the bar (9.4) and the flanking support (8.1) in the lid portion of the backing support forms a compartment (6) acting as a reservoir for redundant or excess sample solution.
- the flanking supports (8.1) and (8.2) and the taps (7) are separating the reservoir of sample solution from the test strip and forces the fluid to pass the appropriate filter layers (not shown) .
- Fig. 9 is a sectional side view of the lid-provided backing support (1) with the lid (2) closed without pretreatment layers and test strip.
- the aperture (3) in the lid (2) is shaped to divert the sample and eluting buffer into the filter layers (not shown) .
- Bars (9.1), (9.2), (9.3) and (9.4), flanking supports (8.1) and (8.2) and taps (7) which fix the position of the filters are shown.
- the side wall (1.1) of the backing support (1) is shown from its inside.
- the lid (2) and the supporting back (1) are connected by the fastening means or hinge (A) .
- Fig. 10 depicts the test device seen from above and with a transparent closed lid (2) snapped by means for closing the lid and keeping it in place i.e. snapping means (C) on the backing support (1) and without the pretreatment layers and the test strip.
- the hinges (A) are placed in the rear of the test device in the preferred embodiment of the present invention.
- the aperture (3) as well as the flanking supports (8.2) and the taps (7) can be placed for example as indicated.
- the flanking support (8.1) and the bar (9.4) forms a compartment (6) for excess or redundant sample solution.
- Serum ferritin concentration indicates the level of iron stores of the body.
- Ferritin is an early marker of iron deficiency anemia (IDA) because its concentration decreases before anemia has developed. Prelatent and latent anemia is detectable before a decrease in hemoglobin concentration can be observed.
- IDA iron deficiency anemia
- the rapid test described below for determining ferritin can be used to estimate the need for iron therapy during the pregnancy.
- the test was performed on whole blood.
- the cut-off value was about 40 ⁇ g/1 (calibrated against WHO 3rd International Standard, code 94/572) .
- the positive test result indicated, that the risk of developing IDA later in pregnancy was small, and no iron therapy should be needed.
- the negative test result indicated, that the risk of developing IDA was big, and therefore iron therapy should be recommended.
- the test was based on lateral flow immunochromatography using monoclonal antibodies against human ferritin. One antibody was bound to colored microspheres , and another antibody was dispensed onto a membrane solid phase.
- the test device was composed of a lateral flow test strip and filters for separation of red blood cells from whole blood mounted in the lid-provided pretreatment portion.
- test device was assembled so that at first the test strip was placed into the plastic device, then the filter layers were mounted into their places, and finally the lid was closed.
- the test device was packed into aluminium foil pouches together with silica gel bags.
- test result was read visually or by a reader 5 minutes after addition of elution buffer.
- One line (control line) in the test window indicated a negative test result.
- Two lines (test line and control line) in the test window indicated a positive result.
- Samples for environmental fungal analysis e.g. analysis for Sta.ch.ybo try s chartarum, were collected from suitable sites identified by the investigator as representing the contaminated area sufficiently.
- the sample was taken from a site including building material, other substrate, accumulated dust etc.
- the sample was transferred into a test tube containing buffer solution and shaken carefully.
- the sample suspension was then transferred into a test device.
- the test device consisted of an immunochromatographic test stick for recognizing Stachy- botrys chartarum and a pretreatment device.
- the lid-provided pretreatment device was assembled by placing two pads of porous material in the plastic compartment. The first pad was impregnated with reagents that were capable of releasing anti- genic cell components present in the fungal cell wall.
- the second pad was made of filtering material capable of removing large particles of fungal structure. If necessary, one more pad can be added, containing immobilized antibodies that capture components that might cause nonspecific reactions with the antibodies used in the immunochromatographic test stick. Sample suspension in buffer was pipetted into the aperture in the lid. Within 5 minutes, the sample liquid migrated through the pads for pretreatment and along the test strip. When fungal antigen were present a visible line was formed in the test strip and the test was interpreted as positive. In other words, the site inspected was contaminated by the indicator fungus, Stachybotris chartrum .
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001532099A JP2003512624A (en) | 1999-10-21 | 2000-10-20 | Apparatus with test strip with pretreatment section with lid |
AU79286/00A AU7928600A (en) | 1999-10-21 | 2000-10-20 | A test strip provided device with a lid-provided pretreatment portion |
EP00969615A EP1222458A1 (en) | 1999-10-21 | 2000-10-20 | A test strip provided device with a lid-provided pretreatment portion |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI19992286 | 1999-10-21 | ||
FI992286 | 1999-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001029558A1 true WO2001029558A1 (en) | 2001-04-26 |
Family
ID=8555487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2000/000914 WO2001029558A1 (en) | 1999-10-21 | 2000-10-20 | A test strip provided device with a lid-provided pretreatment portion |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1222458A1 (en) |
JP (1) | JP2003512624A (en) |
CN (1) | CN1145796C (en) |
AU (1) | AU7928600A (en) |
WO (1) | WO2001029558A1 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003016352A1 (en) * | 2001-08-10 | 2003-02-27 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Monoclonal antibodies against fungi and methods for their use |
EP1538444A1 (en) * | 2003-12-05 | 2005-06-08 | HUMAN Gesellschaft für Biochemica und Diagnostica mbH | Testing device |
GB2435927A (en) * | 2006-03-03 | 2007-09-12 | Ethicon Inc | Sample collection and testing device with pivot arm |
EP1908522A1 (en) * | 2006-10-03 | 2008-04-09 | Meridian Bioscience, Inc. | Immunoassay test device and method of use |
US8119393B2 (en) | 2005-06-28 | 2012-02-21 | Zbx Corporation | Membrane array and analytical device |
JP2012168051A (en) * | 2011-02-15 | 2012-09-06 | Beseru:Kk | Inspection vessel used for immunochromatography |
EP2560005A1 (en) * | 2010-04-14 | 2013-02-20 | Nitto Boseki Co., Ltd | Test instrument for measuring analyte in sample, and method for measuring analyte using same |
US8877142B2 (en) | 2006-06-20 | 2014-11-04 | Johnson & Johnson Ab | Assay device and method |
US9168526B2 (en) | 2009-06-19 | 2015-10-27 | Zbx Corporation | Hinged cap for diagnostic device |
EP3028765A1 (en) * | 2005-01-31 | 2016-06-08 | Realbio Technologies Ltd. | Multistep reaction lateral flow capillary device |
US9726581B2 (en) | 2011-12-22 | 2017-08-08 | Realbio Technologies Ltd. | Sequential lateral flow capillary device for analyte determination |
CN107727648A (en) * | 2017-10-25 | 2018-02-23 | 上海菲伽生物科技有限公司 | Test paper color reaction accelerator |
US9952211B2 (en) | 2008-06-29 | 2018-04-24 | Realbio Technologies Ltd. | Liquid-transfer device particularly useful as a capturing device in a biological assay process |
US10048262B2 (en) | 2012-06-13 | 2018-08-14 | Asahi Kasei Kabushiki Kaisha | Method for detecting specific substance in milk |
US10073091B2 (en) | 2014-08-08 | 2018-09-11 | Ortho-Clinical Diagnostics, Inc. | Lateral flow assay device |
WO2020127837A3 (en) * | 2018-12-19 | 2020-09-24 | Gentian As | Methods for determining the hematocrit level in a sample of whole blood |
CN112903744A (en) * | 2019-12-04 | 2021-06-04 | 爱尔伯股份公司 | Test strip support |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100883555B1 (en) * | 2005-11-15 | 2009-02-17 | 한메딕스 주식회사 | Novel quantitative and qualitative analysis apparatus for measuring the body fluid |
CN101017169B (en) * | 2006-07-26 | 2012-07-18 | 艾博生物医药(杭州)有限公司 | Analysis equipment of biological sample |
JP5249534B2 (en) * | 2007-07-09 | 2013-07-31 | 大塚製薬株式会社 | Test paper measuring container |
KR101894100B1 (en) * | 2012-02-29 | 2018-08-31 | 고려대학교 산학협력단 | Bio sensor |
CN104142392B (en) * | 2014-08-18 | 2015-12-09 | 深圳市领治医学科技有限公司 | A kind of trace sample Test paper |
US9377457B1 (en) * | 2015-10-19 | 2016-06-28 | Naishu Wang | Progressive compression driven flow cartridge for analyte detecting strip and method |
JP6692061B2 (en) * | 2016-02-05 | 2020-05-13 | 公益財団法人科学技術交流財団 | Holder and inspection kit |
CN106645681B (en) * | 2016-10-31 | 2018-12-18 | 广州科方生物技术股份有限公司 | A kind of blocking agent kit and its application method for immunochromatographic measurement |
US10634591B2 (en) * | 2017-03-13 | 2020-04-28 | Tokitae Llc | Device for concentration of biological sample prior to immunoassay |
JP6985921B2 (en) * | 2017-12-20 | 2021-12-22 | 積水メディカル株式会社 | Device for immunochromatography |
CN110018301B (en) * | 2018-01-09 | 2024-06-25 | 上海八通生物科技股份有限公司 | Combined immunochromatography device |
CN108982832A (en) * | 2018-09-28 | 2018-12-11 | 蓝怡科技集团股份有限公司 | A kind of immunodiagnosis detection device |
WO2021015273A1 (en) * | 2019-07-23 | 2021-01-28 | 田中貴金属工業株式会社 | Liquid sample inspection tool |
CN111474352B (en) * | 2020-04-29 | 2023-12-22 | 北京乐普诊断科技股份有限公司 | Novel coronavirus COVID-2019 detection card and preparation method thereof |
CN113281504B (en) * | 2020-11-11 | 2022-03-08 | 杭州微策生物技术股份有限公司 | Novel immunochromatography detection device |
WO2022253108A1 (en) * | 2021-06-02 | 2022-12-08 | 厦门为正生物科技股份有限公司 | Folding testing apparatus and method for using same |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985005686A1 (en) * | 1982-12-29 | 1985-12-19 | Polaroid Corporation | Multilayer element for analysis |
EP0306336A2 (en) * | 1987-09-04 | 1989-03-08 | Syntex (U.S.A.) Inc. | Multiple port assay device |
EP0323605A2 (en) * | 1987-12-21 | 1989-07-12 | Abbott Laboratories | Chromatographic binding assay devices and methods |
EP0582231A1 (en) * | 1992-08-03 | 1994-02-09 | Becton, Dickinson and Company | Solid phase assay |
WO1994015215A1 (en) * | 1992-12-29 | 1994-07-07 | Oy Medix Biochemica Ab | Test strip for immunoassays |
EP0806666A2 (en) * | 1996-05-09 | 1997-11-12 | Syntron Bioresearch, Inc. | Method and apparatus for single step assays of whole blood |
US5820826A (en) * | 1992-09-03 | 1998-10-13 | Boehringer Mannheim Company | Casing means for analytical test apparatus |
US5985675A (en) * | 1997-12-31 | 1999-11-16 | Charm Sciences, Inc. | Test device for detection of an analyte |
-
2000
- 2000-10-20 AU AU79286/00A patent/AU7928600A/en not_active Abandoned
- 2000-10-20 EP EP00969615A patent/EP1222458A1/en not_active Withdrawn
- 2000-10-20 WO PCT/FI2000/000914 patent/WO2001029558A1/en not_active Application Discontinuation
- 2000-10-20 CN CNB008146152A patent/CN1145796C/en not_active Expired - Fee Related
- 2000-10-20 JP JP2001532099A patent/JP2003512624A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985005686A1 (en) * | 1982-12-29 | 1985-12-19 | Polaroid Corporation | Multilayer element for analysis |
EP0306336A2 (en) * | 1987-09-04 | 1989-03-08 | Syntex (U.S.A.) Inc. | Multiple port assay device |
EP0323605A2 (en) * | 1987-12-21 | 1989-07-12 | Abbott Laboratories | Chromatographic binding assay devices and methods |
EP0582231A1 (en) * | 1992-08-03 | 1994-02-09 | Becton, Dickinson and Company | Solid phase assay |
US5820826A (en) * | 1992-09-03 | 1998-10-13 | Boehringer Mannheim Company | Casing means for analytical test apparatus |
WO1994015215A1 (en) * | 1992-12-29 | 1994-07-07 | Oy Medix Biochemica Ab | Test strip for immunoassays |
EP0806666A2 (en) * | 1996-05-09 | 1997-11-12 | Syntron Bioresearch, Inc. | Method and apparatus for single step assays of whole blood |
US5985675A (en) * | 1997-12-31 | 1999-11-16 | Charm Sciences, Inc. | Test device for detection of an analyte |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003016352A1 (en) * | 2001-08-10 | 2003-02-27 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Monoclonal antibodies against fungi and methods for their use |
US7368256B2 (en) | 2001-08-10 | 2008-05-06 | United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Antibodies against Stachybotrys chartarum and methods for their use |
EP1538444A1 (en) * | 2003-12-05 | 2005-06-08 | HUMAN Gesellschaft für Biochemica und Diagnostica mbH | Testing device |
US10335783B2 (en) | 2005-01-31 | 2019-07-02 | Realbio Technologies, Ltd. | Multistep reaction lateral flow capillary device |
EP3028765A1 (en) * | 2005-01-31 | 2016-06-08 | Realbio Technologies Ltd. | Multistep reaction lateral flow capillary device |
US8119393B2 (en) | 2005-06-28 | 2012-02-21 | Zbx Corporation | Membrane array and analytical device |
AU2007220303B2 (en) * | 2006-03-03 | 2012-08-23 | Ethicon, Inc. | Sample collection and testing device with pivot arm |
GB2435927A (en) * | 2006-03-03 | 2007-09-12 | Ethicon Inc | Sample collection and testing device with pivot arm |
US9606112B2 (en) | 2006-06-20 | 2017-03-28 | Johnson & Johnson Ab | Assay device and method |
US8877142B2 (en) | 2006-06-20 | 2014-11-04 | Johnson & Johnson Ab | Assay device and method |
AU2007205745B2 (en) * | 2006-10-03 | 2011-03-03 | Meridian Bioscience, Inc. | Immunoassay test device and method of use |
EP1908522A1 (en) * | 2006-10-03 | 2008-04-09 | Meridian Bioscience, Inc. | Immunoassay test device and method of use |
US11280785B2 (en) | 2008-06-29 | 2022-03-22 | Realbio Technologies Ltd. | Liquid-transfer device particularly useful as a capturing device in a biological assay process |
US9952211B2 (en) | 2008-06-29 | 2018-04-24 | Realbio Technologies Ltd. | Liquid-transfer device particularly useful as a capturing device in a biological assay process |
US9168526B2 (en) | 2009-06-19 | 2015-10-27 | Zbx Corporation | Hinged cap for diagnostic device |
EP2560005A4 (en) * | 2010-04-14 | 2014-04-09 | Nitto Boseki Co Ltd | Test instrument for measuring analyte in sample, and method for measuring analyte using same |
EP2560005A1 (en) * | 2010-04-14 | 2013-02-20 | Nitto Boseki Co., Ltd | Test instrument for measuring analyte in sample, and method for measuring analyte using same |
US10670586B2 (en) | 2010-04-14 | 2020-06-02 | Nitto Boseki Co., Ltd. | Test instrument for measuring analyte in sample by an aggregation assay using a metal colloid and using a reagent attached in a dry state in a reaction chamber, and method for measuring analyte using same |
JP2012168051A (en) * | 2011-02-15 | 2012-09-06 | Beseru:Kk | Inspection vessel used for immunochromatography |
US9726581B2 (en) | 2011-12-22 | 2017-08-08 | Realbio Technologies Ltd. | Sequential lateral flow capillary device for analyte determination |
US10048262B2 (en) | 2012-06-13 | 2018-08-14 | Asahi Kasei Kabushiki Kaisha | Method for detecting specific substance in milk |
US10545146B2 (en) | 2012-06-13 | 2020-01-28 | Asahi Kasei Kabushiki Kaisha | Method for detecting specific substance in milk |
US10073091B2 (en) | 2014-08-08 | 2018-09-11 | Ortho-Clinical Diagnostics, Inc. | Lateral flow assay device |
CN107727648A (en) * | 2017-10-25 | 2018-02-23 | 上海菲伽生物科技有限公司 | Test paper color reaction accelerator |
WO2020127837A3 (en) * | 2018-12-19 | 2020-09-24 | Gentian As | Methods for determining the hematocrit level in a sample of whole blood |
CN112903744A (en) * | 2019-12-04 | 2021-06-04 | 爱尔伯股份公司 | Test strip support |
Also Published As
Publication number | Publication date |
---|---|
CN1382257A (en) | 2002-11-27 |
CN1145796C (en) | 2004-04-14 |
EP1222458A1 (en) | 2002-07-17 |
JP2003512624A (en) | 2003-04-02 |
AU7928600A (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1222458A1 (en) | A test strip provided device with a lid-provided pretreatment portion | |
AU2002330899B2 (en) | Test strip for a lateral flow assay | |
RU2358267C2 (en) | Device and method of simultaneous definition of blood type, serological cross-check and antibody analysis | |
AU2009233694B2 (en) | Analyte collection and detection devices | |
EP0296724B1 (en) | Assay and apparatus using a lateral flow, non-bibulous membrane | |
US9606112B2 (en) | Assay device and method | |
EP0806666B1 (en) | Method and apparatus for single step assays of whole blood | |
DK1824991T3 (en) | Device and method for the detection of analytes | |
US7288413B2 (en) | Combined chemical and immunochemical fecal occult blood test | |
CA2493616A1 (en) | Rapid diagnostic device, assay and multifunctional buffer | |
US5759866A (en) | Device and method for assaying biological components in sample | |
AU2002330899A1 (en) | Test strip for a lateral flow assay | |
US5753497A (en) | Diagnostic assay providing blood separation | |
JPH0627738B2 (en) | Specific binding assay device and method | |
KR20060109595A (en) | Improved lateral flow immunoassay and device therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000969615 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 532099 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008146152 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10089541 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000969615 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000969615 Country of ref document: EP |